Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenström Macroglobulinemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenström Macroglobulinemia
J. Clin. Oncol 2020 Sep 15;[EPub Ahead of Print], SP Treon, K Meid, J Gustine, G Yang, L Xu, X Liu, CJ Patterson, ZR Hunter, AR Branagan, JP Laubach, IM Ghobrial, ML Palomba, R Advani, JJ CastilloFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.